Sonendo (SONX) Competitors

$0.61 0.00 (0.00%)

As of 05/22/2026

SONX vs. LFWD, QNRX, SINT, CODX, and TNON

Should you buy Sonendo stock or one of its competitors? MarketBeat compares Sonendo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sonendo include Lifeward (LFWD), Quoin Pharmaceuticals (QNRX), Sintx Technologies (SINT), Co-Diagnostics (CODX), and Tenon Medical (TNON). These companies are all part of the "medical equipment" industry.

How does Sonendo compare to Lifeward?

Sonendo (NYSE:SONX) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

Sonendo has a beta of 2.19, suggesting that its stock price is 119% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market.

Lifeward has a consensus price target of $10.00, indicating a potential upside of 41.84%. Given Lifeward's stronger consensus rating and higher possible upside, analysts clearly believe Lifeward is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Lifeward	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

28.7% of Sonendo shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 7.9% of Sonendo shares are held by insiders. Comparatively, 1.5% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Lifeward had 3 more articles in the media than Sonendo. MarketBeat recorded 3 mentions for Lifeward and 0 mentions for Sonendo. Lifeward's average media sentiment score of 0.16 beat Sonendo's score of 0.00 indicating that Lifeward is being referred to more favorably in the news media.

Company	Overall Sentiment
Sonendo	Neutral
Lifeward	Neutral

Lifeward has lower revenue, but higher earnings than Sonendo. Lifeward is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.07	-$60.92M	-$71.12	N/A
Lifeward	$22.03M	0.49	-$19.91M	-$19.66	N/A

Sonendo has a net margin of -92.74% compared to Lifeward's net margin of -123.66%. Sonendo's return on equity of -184.01% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Lifeward	-123.66%	-243.14%	-97.39%

Summary

Sonendo and Lifeward tied by winning 8 of the 16 factors compared between the two stocks.

How does Sonendo compare to Quoin Pharmaceuticals?

Sonendo (NYSE:SONX) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

In the previous week, Quoin Pharmaceuticals had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for Quoin Pharmaceuticals and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 equaled Quoin Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Sonendo	Neutral
Quoin Pharmaceuticals	Neutral

Sonendo has a beta of 2.19, meaning that its share price is 119% more volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market.

Quoin Pharmaceuticals has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. 7.9% of Sonendo shares are owned by company insiders. Comparatively, 13.5% of Quoin Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Quoin Pharmaceuticals has lower revenue, but higher earnings than Sonendo. Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.07	-$60.92M	-$71.12	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A

Summary

Sonendo and Quoin Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks.

How does Sonendo compare to Sintx Technologies?

Sonendo (NYSE:SONX) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Sonendo has a net margin of -92.74% compared to Sintx Technologies' net margin of -1,058.60%. Sonendo's return on equity of -184.01% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Sintx Technologies	-1,058.60%	-366.49%	-115.04%

Sintx Technologies has a consensus target price of $11.00, indicating a potential upside of 360.25%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 7.9% of Sonendo shares are owned by company insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Sonendo has a beta of 2.19, meaning that its stock price is 119% more volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Sintx Technologies has lower revenue, but higher earnings than Sonendo. Sintx Technologies is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.07	-$60.92M	-$71.12	N/A
Sintx Technologies	$1.02M	10.12	-$10.36M	-$5.07	N/A

In the previous week, Sintx Technologies had 10 more articles in the media than Sonendo. MarketBeat recorded 10 mentions for Sintx Technologies and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 equaled Sintx Technologies'average media sentiment score.

Company	Overall Sentiment
Sonendo	Neutral
Sintx Technologies	Neutral

Summary

Sonendo beats Sintx Technologies on 8 of the 15 factors compared between the two stocks.

How does Sonendo compare to Co-Diagnostics?

Sonendo (NYSE:SONX) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

Co-Diagnostics has a consensus price target of $67.50, suggesting a potential upside of 1,231.36%. Given Co-Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Co-Diagnostics is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Co-Diagnostics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Co-Diagnostics has lower revenue, but higher earnings than Sonendo. Co-Diagnostics is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.07	-$60.92M	-$71.12	N/A
Co-Diagnostics	$620K	29.44	-$46.90M	-$15.77	N/A

Sonendo has a beta of 2.19, indicating that its share price is 119% more volatile than the broader market. Comparatively, Co-Diagnostics has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

In the previous week, Co-Diagnostics had 7 more articles in the media than Sonendo. MarketBeat recorded 7 mentions for Co-Diagnostics and 0 mentions for Sonendo. Co-Diagnostics' average media sentiment score of 0.05 beat Sonendo's score of 0.00 indicating that Co-Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
Sonendo	Neutral
Co-Diagnostics	Neutral

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 7.9% of Sonendo shares are owned by insiders. Comparatively, 5.4% of Co-Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Sonendo has a net margin of -92.74% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Co-Diagnostics	-6,760.63%	-164.92%	-141.15%

Summary

Co-Diagnostics beats Sonendo on 9 of the 16 factors compared between the two stocks.

How does Sonendo compare to Tenon Medical?

Sonendo (NYSE:SONX) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, Tenon Medical had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for Tenon Medical and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 equaled Tenon Medical'saverage media sentiment score.

Company	Overall Sentiment
Sonendo	Neutral
Tenon Medical	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Tenon Medical has lower revenue, but higher earnings than Sonendo. Tenon Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.07	-$60.92M	-$71.12	N/A
Tenon Medical	$3.94M	2.11	-$12.56M	-$1.29	N/A

Sonendo has a net margin of -92.74% compared to Tenon Medical's net margin of -270.09%. Sonendo's return on equity of -184.01% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Tenon Medical	-270.09%	-907.60%	-110.17%

Sonendo has a beta of 2.19, indicating that its stock price is 119% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market.

28.7% of Sonendo shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 7.9% of Sonendo shares are held by insiders. Comparatively, 0.3% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Sonendo beats Tenon Medical on 8 of the 14 factors compared between the two stocks.

Get Sonendo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SONX vs. The Competition

Export

Metric	Sonendo	Dental equipment & supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$2.91M	$2.91M	$6.46B	$23.20B
Dividend Yield	N/A	N/A	2.76%	4.10%
P/E Ratio	-0.01	N/A	20.99	30.65
Price / Sales	0.07	0.07	556.56	24.50
Price / Cash	N/A	N/A	43.49	25.12
Price / Book	0.01	0.01	10.44	4.74
Net Income	-$60.92M	-$60.92M	$3.57B	$1.07B
7 Day Performance	N/A	N/A	6.39%	2.36%
1 Month Performance	84.85%	84.85%	3.53%	1.58%
1 Year Performance	-59.87%	-59.87%	34.12%	28.42%

Sonendo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SONX Sonendo	N/A	$0.61 flat	N/A	-59.9%	$2.91M	$44.40M	N/A	250
LFWD Lifeward	1.936 of 5 stars	$6.27 -3.4%	$10.00 +59.5%	-53.4%	$9.92M	$22.03M	N/A	60	Gap Down
QNRX Quoin Pharmaceuticals	0.112 of 5 stars	$4.85 -1.8%	N/A	-46.0%	$9.92M	N/A	N/A	4	Positive News High Trading Volume
SINT Sintx Technologies	2.667 of 5 stars	$2.30 +4.1%	$11.00 +378.3%	-11.2%	$9.55M	$1.02M	N/A	40	Gap Down
CODX Co-Diagnostics	1.956 of 5 stars	$3.71 +55.2%	$67.50 +1,719.4%	-27.0%	$8.61M	$620K	N/A	100	Analyst Upgrade Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SONX) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sonendo (SONX) Competitors

SONX vs. LFWD, QNRX, SINT, CODX, and TNON

How does Sonendo compare to Lifeward?

Summary

How does Sonendo compare to Quoin Pharmaceuticals?

Summary

How does Sonendo compare to Sintx Technologies?

Summary

How does Sonendo compare to Co-Diagnostics?

Summary

How does Sonendo compare to Tenon Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sonendo (SONX) Competitors

SONX vs. LFWD, QNRX, SINT, CODX, and TNON

How does Sonendo compare to Lifeward?

Which has more risk & volatility, SONX or LFWD?

Do analysts prefer SONX or LFWD?

Do institutionals and insiders hold more shares of SONX or LFWD?

Does the media favor SONX or LFWD?

Which has higher valuation and earnings, SONX or LFWD?

Is SONX or LFWD more profitable?

Summary

How does Sonendo compare to Quoin Pharmaceuticals?

Does the media favor SONX or QNRX?

Which has more risk & volatility, SONX or QNRX?

Is SONX or QNRX more profitable?

Do analysts recommend SONX or QNRX?

Do institutionals & insiders hold more shares of SONX or QNRX?

Which has preferable earnings and valuation, SONX or QNRX?

Summary

How does Sonendo compare to Sintx Technologies?

Is SONX or SINT more profitable?

Do analysts recommend SONX or SINT?

Do institutionals and insiders believe in SONX or SINT?

Which has more risk and volatility, SONX or SINT?

Which has stronger earnings and valuation, SONX or SINT?

Does the media favor SONX or SINT?

Summary

How does Sonendo compare to Co-Diagnostics?

Do analysts rate SONX or CODX?

Which has better valuation and earnings, SONX or CODX?

Which has more risk and volatility, SONX or CODX?

Does the media favor SONX or CODX?

Do insiders & institutionals hold more shares of SONX or CODX?

Is SONX or CODX more profitable?

Summary

How does Sonendo compare to Tenon Medical?

Does the media favor SONX or TNON?

Do analysts rate SONX or TNON?

Which has preferable valuation and earnings, SONX or TNON?

Is SONX or TNON more profitable?

Which has more risk & volatility, SONX or TNON?

Do insiders and institutionals believe in SONX or TNON?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools